日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Induction of the p21/CDK6 pathway and alteration of the immune microenvironment by the stem cell marker CBX3 in melanoma.

黑色素瘤中干细胞标志物 CBX3 诱导 p21/CDK6 通路并改变免疫微环境

期刊:Stem Cell Research & Therapy
影响因子:7.3
doi:10.1186/s13287-025-04179-8
Chen Wanxian, Zhou Linsa, Jiang Jingjing, Chen Jiasheng, Geng Deyi, Chen Yaokun, Han Xiaosha, Xie Qihu, Guo Genghong, Chen Xuefen, Tang Shijie, Zhong Xiaoping
发育与干细胞
细胞生物学
黑色素瘤
CDK6
发表日期：2025
文献求助 收藏

A study on the therapeutic effect of precise clipping of intracranial aneurysms assisted by CTA and 3D-slicer software

一项关于CTA和3D切片软件辅助下精确夹闭颅内动脉瘤的治疗效果研究

期刊:Frontiers in Surgery
影响因子:1.8
doi:10.3389/fsurg.2025.1535585
He, Chuan; Cao, Gang; Yang, Ying; Zhong, Qi; Lei, Yongsheng; Tan, Xingshi; Lin, Xiaohong; Chen, Yaokun; Sun, Wenxiao
3D/类器官
心血管
动脉瘤
发表日期：2025
文献求助 收藏

Comparative efficacy and safety of different combinations of three CDK4/6 inhibitors with endocrine therapies in HR+/HER-2 - metastatic or advanced breast cancer patients: a network meta-analysis

三种 CDK4/6 抑制剂与内分泌疗法不同组合在 HR+/HER-2 阴性转移性或晚期乳腺癌患者中的疗效和安全性比较：一项网络荟萃分析

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-023-11322-2
Liu, Yiyuan; Wu, Jinyao; Ji, Zeqi; Chen, Lingzhi; Zou, Juan; Zheng, Jiehua; Lin, Weixun; Cai, Jiehui; Chen, Yaokun; Zheng, Daitian; Chen, Yexi; Li, Zhiyang
CDK4
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

Addition of Capecitabine to Adjuvant Chemotherapy May be the Most Effective Strategy for Patients With Early-Stage Triple-Negative Breast Cancer: A Network Meta-Analysis of 9 Randomized Controlled Trials

卡培他滨联合辅助化疗可能是早期三阴性乳腺癌患者最有效的治疗策略：一项包含9项随机对照试验的网络荟萃分析

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2022.939048
Li, Zhiyang; Zheng, Jiehua; Ji, Zeqi; Chen, Lingzhi; Wu, Jinyao; Zou, Juan; Liu, Yiyuan; Lin, Weixun; Cai, Jiehui; Chen, Yaokun; Chen, Yexi; Lu, Hai
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

Global Trends in Research of Androgen Receptor Associated With Breast Cancer From 2011 to 2020: A Scientometric Analysis

2011年至2020年全球乳腺癌相关雄激素受体研究趋势：一项科学计量学分析

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2022.887612
Chen, Lingzhi; Liu, Yiyuan; Cai, Jiehui; Ji, Zeqi; Zou, Juan; Chen, Yaokun; Wu, Jinyao; Zheng, Daitian; Zheng, Jiehua; Chen, Yexi; Li, Zhiyang
肿瘤
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2022
文献求助 收藏

Identification and Validation of a Four-Gene Ferroptosis Signature for Predicting Overall Survival of Lung Squamous Cell Carcinoma

鉴定和验证用于预测肺鳞状细胞癌总生存期的四基因铁死亡特征

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2022.933925
Wang, Qi; Chen, Yaokun; Gao, Wen; Feng, Hui; Zhang, Biyuan; Wang, Haiji; Lu, Haijun; Tan, Ye; Dong, Yinying; Xu, Mingjin
细胞生物学
肿瘤
铁死亡
肿瘤免疫
发表日期：2022
文献求助 收藏

Global research trends on anti-PD-1/anti-PD-L1 immunotherapy for triple-negative breast cancer: A scientometric analysis

全球抗PD-1/抗PD-L1免疫疗法治疗三阴性乳腺癌的研究趋势：一项科学计量学分析

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2022.1002667
Wu, Jinyao; Chen, Yaokun; Chen, Lingzhi; Ji, Zeqi; Tian, Huiting; Zheng, Daitian; Yang, Qiuping; Liu, Yiyuan; Cai, Jiehui; Zheng, Jiehua; Chen, Yexi; Li, Zhiyang
肿瘤
肿瘤免疫
乳腺癌
PD-L1
PD-1
免疫/内分泌
发表日期：2022
文献求助 收藏

Development and validation of a novel endoplasmic reticulum stress-related lncRNA prognostic signature and candidate drugs in breast cancer

开发和验证一种新型内质网应激相关lncRNA预后特征及其在乳腺癌中的候选药物

期刊:Frontiers in Genetics
影响因子:2.8
doi:10.3389/fgene.2022.949314
Cai, Jiehui; Ji, Zeqi; Wu, Jinyao; Chen, Lingzhi; Zheng, Daitian; Chen, Yaokun; Zhang, Xinkang; Xie, Wanchun; Huang, Jieying; Chen, Manqi; Lin, Ru; Lin, Weixun; Chen, Yexi; Li, Zhiyang
乳腺癌
lncRNA
肿瘤
肿瘤免疫
内质网应激
发表日期：2022
文献求助 收藏

Effect of Previous Cancer History on Survival of Patients with Different Subtypes of Breast Cancer

既往癌症史对不同亚型乳腺癌患者生存率的影响

期刊:Biomed Research International
影响因子:2.3
doi:10.1155/2022/6116658
Lin, Weixun; Chen, Yaokun; Ji, Zeqi; Chen, Lingzhi; Wu, Jinyao; Chen, Yexi; Li, Zhiyang
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

The Global, Regional, and National Burden and Trends of Breast Cancer From 1990 to 2019: Results From the Global Burden of Disease Study 2019

1990年至2019年全球、区域和国家乳腺癌负担及趋势：2019年全球疾病负担研究结果

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2021.689562
Xu, Shangbo; Liu, Yiyuan; Zhang, Taofeng; Zheng, Jiehua; Lin, Weixun; Cai, Jiehui; Zou, Juan; Chen, Yaokun; Xie, Yanna; Chen, Yexi; Li, Zhiyang
肿瘤
肿瘤免疫
乳腺癌
发表日期：2021
文献求助 收藏